Latency Reversal plus Natural Killer Cells Diminish HIV Reservoir In Vivo

Investigators showed the administration of allogeneic human peripheral blood natural killer cells delays viral rebound following interruption of anti-retroviral therapy in humanized mice infected with HIV-1.